Repairogen Pitch Deck Teardown: A Science-Heavy Look

Repairogen Pitch Deck Analysis

The Repairogen pitch deck, dated January 2016, is a concise 10-slide presentation that focuses heavily on the scientific validation of a new skincare compound. The deck follows a traditional problem-solution-evidence flow but stops short of providing the business and financial details typically required for a full investment round. It functions more as a 'teaser' or a technical validation deck for strategic partners or early-stage angel investors who prioritize clinical efficacy over immediate revenue models.

Slide 1: Title Slide

The deck opens with the Repairogen logo and the tagline: "Skin Damage Happens. Repairogen Can Help." It is a minimalist start that establishes the brand name and the general sector (skincare) without clutter. There is no mention of the specific funding round or the date on this slide, though the footer on subsequent slides indicates January 2016.

Slide 2: Our Mission

The mission statement is clear: "To develop the leading DNA-based skin repair solution that improves skin health and appearance." The slide uses a before-and-after background image of a woman's face to visually represent the desired outcome of the product. This slide sets the stage for a biotechnology-focused approach to cosmetics, often referred to as 'cosmeceuticals.'

Slide 3: Why This Matters

This slide serves as the 'Problem' slide. It identifies UV radiation and pollution as the primary environmental factors that damage skin DNA, leading to cell death and destruction. The use of simple icons (sun, person, factory) keeps the message high-level, focusing on the universal nature of the problem rather than niche medical conditions.

Slide 4: Our Innovative Solution

Repairogen introduces its value proposition here. The company claims to have screened over 150,000 naturally occurring compounds . A Venn diagram illustrates their 'sweet spot': compounds that are Natural Actives, Skin Penetrable, and Multi-Functional. This slide is critical because it suggests a proprietary discovery process that led to their specific active ingredients.

Slide 5: Evidence of Skin Repair

This is the first of two heavy data slides. It presents a bar chart showing the percentage of CPD DNA (a marker of damage) after UV exposure. According to the chart, the compound RGN0001 1nM reduced DNA damage by 63% after 12 hours and 47% after 24 hours compared to a vehicle control. This slide provides the scientific 'teeth' the deck needs to justify its claims of being a DNA-based repair solution.

Slide 6: Evidence of Skin Cancer Protection

The deck moves from cosmetic repair to medical protection. This slide shows a Kaplan-Meier-style curve of mice under UV irradiation. The text states that ">90% of mice in test did not develop skin cancer" over a 45-week period, whereas the control group saw a significant drop-off in cancer-free subjects starting around week 30. This is a bold claim that positions the technology as potentially more than just a beauty product.

Slide 7: Anti-Aging Skin Care Market

The market slide uses data from Euromonitor 2015. It highlights that premium anti-aging products are the fastest-growing segment, with a 5-year CAGR of 34% . The bar chart shows spend in billions, with the 'Premium facial' category growing from roughly $0.5 billion in 2010 to over $2.0 billion in 2014 . This slide validates the commercial appetite for high-end skincare solutions.

Slide 8: Dermatologists Want Repairogen

For traction, the company presents survey results from 27 dermatologists . Key metrics include: 63% would recommend Repairogen to 40% of their patients . The slide also displays logos for Advanced Dermatology & Skin Cancer Center, California Skin Institute, and The Dermatology Group, P.C., providing third-party validation from practitioners in the field.

Slide 9: Exceptional Team

The team slide lists three senior management members and two advisors:

Frank Borchetta, JD: CEO · Michael Boice, PhD: CSO · Jesse Sandoval: Director of Sales · Nava Dayan, PhD: Scientific Advisor and Consultant · Louis Walcer, MBA: Director of Cornell University McGovern Center Incubator

The presence of a JD and a PhD in the top two spots suggests a focus on intellectual property and research, while the Cornell incubator connection adds institutional credibility.

Slide 10: Contact Information

The final slide provides direct email addresses and phone numbers for the CEO and CSO. It repeats the logo and maintains the blue-and-white color scheme used throughout the deck.

What Repairogen Does Well

The deck is exceptionally strong on scientific validation . In an industry (skincare) often criticized for 'snake oil' claims, providing specific data on DNA damage reduction (Slide 5) and animal cancer protection (Slide 6) sets a high bar. The focus on a specific compound (RGN0001) suggests that the company has moved past the conceptual phase and into the testing phase.

The market timing slide (Slide 7) is also effective. By narrowing the focus to the 'Premium' segment and showing a 34% CAGR, they make a compelling case that there is a specific, high-growth niche ready for a scientifically-backed product.

What is Missing from the Repairogen Deck

The most glaring omission is the Business Model . The deck does not explain how Repairogen intends to make money. Are they a B2B company licensing this compound to giants like L'Oreal or Estée Lauder? Or are they a B2C company launching their own brand? While they have a 'Director of Sales,' the path to revenue is never explicitly stated.

Furthermore, there is no 'Ask' slide . A pitch deck is a fundraising tool, yet this document never mentions how much capital the company is seeking, what the valuation is, or what the 'Use of Proceeds' will be. Without this, the deck feels like a scientific poster presentation rather than a business proposal.

Finally, there is no Competition slide. The skincare market is notoriously crowded. Even if their DNA-repair mechanism is unique, they are still competing for the same 'Premium' dollars mentioned on Slide 7. Failing to acknowledge competitors makes the founders look less aware of the market landscape.

Founder Takeaways

Founders in the biotech or 'deep tech' space should look at Slide 5 and Slide 6 as examples of how to present complex data simply. The use of clear bar charts and survival curves with highlighted 'key takeaways' (e.g., ">90% of mice...") makes the science accessible to non-PhD investors.

However, founders should avoid the 'science-only' trap. A great product is not a great business. If you are using a deck to raise money, you must include the mechanics of the business: how you get to market, how you beat the competition, and exactly how much money you need to reach the next milestone. Repairogen's deck is a masterclass in 'what' they have built, but a failure in explaining 'how' it becomes a profitable enterprise.